Kiniksa Pharmaceuticals International (KNSA) Treasury Shares (2017 - 2026)

Kiniksa Pharmaceuticals International's Treasury Shares history runs 10 years deep, the most recent figure standing at $421007.0 for Q1 2026.

• Quarterly Treasury Shares fell 80.33% year-over-year to $421007.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421007.0 (down 80.33% YoY) and the FY2025 annual result came in at $2.1 million, down 7.84% from the prior year.
• Treasury Shares was $421007.0 for Q1 2026 at Kiniksa Pharmaceuticals International, up from $415307.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.4 million in Q4 2023 and bottomed at $415307.0 in Q4 2025.
• A 5-year average of $1.8 million and a median of $2.1 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares jumped 148.75% — and 2025, when it sank 81.55%.
• Kiniksa Pharmaceuticals International's Treasury Shares stood at $1.7 million in 2022, then surged by 37.56% to $2.4 million in 2023, then decreased by 6.1% to $2.3 million in 2024, then slumped by 81.55% to $415307.0 in 2025, then increased by 1.37% to $421007.0 in 2026.
• Business Quant data shows KNSA's Treasury Shares at $421007.0 in Q1 2026, $415307.0 in Q4 2025, and $2.2 million in Q3 2025.